| A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications K Lothert, F Pagallies, F Eilts, A Sivanesapillai, M Hardt, A Moebus, ... Journal of Biotechnology 323, 221-230, 2020 | 26 | 2020 |
| Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes K Lothert, F Eilts, MW Wolff Expert Review of Vaccines 21 (8), 1029-1044, 2022 | 21 | 2022 |
| The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics F Eilts, S Bauer, K Fraser, JS Dordick, MW Wolff, RJ Linhardt, F Zhang Carbohydrate Polymers 299, 120167, 2023 | 15 | 2023 |
| Anti-SARS-CoV-2 and anticoagulant properties of Pentacta pygmaea fucosylated chondroitin sulfate depend on high molecular weight structures R Dwivedi, P Sharma, F Eilts, F Zhang, RJ Linhardt, R Tandon, VH Pomin Glycobiology 33 (1), 75-85, 2023 | 15 | 2023 |
| Comparison of sample preparation techniques for the physicochemical characterization of Orf virus particles F Eilts, M Steger, F Pagallies, HJ Rziha, M Hardt, R Amann, MW Wolff Journal of Virological Methods 310, 114614, 2022 | 11 | 2022 |
| A Summary of Practical Considerations for the Application of the Steric Exclusion Chromatography for the Purification of the Orf Viral Vector F Eilts, K Lothert, S Orbay, F Pagallies, R Amann, MW Wolff Membranes 12 (11), 1070, 2022 | 8 | 2022 |
| The Suitability of Latex Particles to Evaluate Critical Process Parameters in Steric Exclusion Chromatography F Eilts, M Steger, K Lothert, MW Wolff Membranes 12 (5), 488, 2022 | 7 | 2022 |
| Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus F Eilts, JJ Labisch, S Orbay, YMJ Harsy, M Steger, F Pagallies, R Amann, ... Vaccine 41 (32), 4731-4742, 2023 | 6 | 2023 |
| Production of Baculovirus and Stem Cells for Baculovirus-Mediated Gene Transfer into Human Mesenchymal Stem Cells F Eilts, J Harnischfeger, D Loewe, MW Wolff, D Salzig, P Czermak Vaccine Delivery Technology: Methods and Protocols, 367-390, 2021 | 4 | 2021 |
| An investigation of excipients for a stable Orf viral vector formulation F Eilts, YMJ Harsy, K Lothert, F Pagallies, R Amann, MW Wolff Virus Research 336, 199213, 2023 | 3 | 2023 |
| Direct affinity ligand immobilization onto bare iron oxide nanoparticles enables efficient magnetic separation of antibodies I Zimmermann, Y Kaveh-Baghbaderani, F Eilts, N Kohn, P Fraga-García, ... ACS Applied Bio Materials 7 (6), 3942-3952, 2024 | 2 | 2024 |
| Purification and concentration of infectious koi herpesvirus using steric exclusion chromatography F Eilts, LK Jordan, YMJ Harsy, SM Bergmann, AM Becker, MW Wolff Journal of Fish Diseases 46 (8), 873-886, 2023 | 1 | 2023 |
| Immobilizing calcium-dependent affinity ligand onto iron oxide nanoparticles for mild magnetic mAb separation I Zimmermann, F Eilts, AS Galler, J Bayer, S Hober, S Berensmeier Biotechnology Reports 45, e00864, 2025 | | 2025 |
| Picking The Best Virus Sample Prep Method In Process Development F Eilts | | 2024 |
| Identification of critical process parameters for the downstream processing of cell culture-derived Orf virus particles F Eilts | | 2023 |
| P2. 3-Kombination optischer Rückstreusensorik und Single-Use-Technologie zur Prozessintensivierung von Zellkultur-Prozessen M Rotter, L Käßer, J Kneitz, F Eilts, G Dekevic, D Salzig, T Hanselmann, ... Poster, 126-131, 2021 | | 2021 |
Michael WolffUniversity of Applied Sciences MittelhessenAdresă de e-mail confirmată pe lse.thm.de